Hill CD, Morlock R, Williams VS, Lenderking W, Feltner D. Identification of placebo responders using the clinical trials site scale (CTSS). Poster presented at the 14th Annual Conference of the International Society for Quality of Life Research; October 2007.
Williams VS, Edin HM, Hogue SL, Fehnel SE, Baldwin DS. Antidepressant-induced sexual dysfunction in three European countries: prevalence and impact in a cross-sectional survey replication. J Psychopharmacol. 2007;21(Suppl):A39.
Williams VSL, Jones G, Mauskopf J, Spalding J, Duchane J. Uterine fibroids: a review of health-related quality of life assessment. J Womens Health. 2006 Sep 7;15(7):818-29.
Williams VS, Feltner D, Hill C, Morlock R. Evaluation of a global anxiety – visual analog scale (GA-VAS) in patients with generalized anxiety disorder. Poster presented at the 19th European College Neuropsychopharmacology Congress; September 2006.
Williams VS, Feltner D, Hill C, Morlock R. Evaluation of a global anxiety – Visual analog scale (ga-vas) in a clinical trial comparing lorazepam and paroxetine in patients with gad. Poster presented at the CINP 25th Biennial Congress; July 2006. [abstract] Int J Neuropsychopharmacol. 2006 Jul; 9(Suppl 1):S118.
Edwards CL, Williams VS, Alford S, Robinson EL. The Alford-Edwards social support inventory: internal consistency reliability. Poster presented at the Annual Scientific Meeting of the Society for Behavioral Medicine; March 2006.
Williams VSL, Baldwin DS, Hogue SL, Fehnel SE, Hollis KA, Edin HM. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry. 2006 Feb 1;67(2):204-10.
Williams VSL, Smith M, Fehnel SE. The validity and utility of the BPI interference measures for evaluating the impact of osteoarthritic pain. J Pain Symptom Manage. 2006 Jan 1;31(1):48-57.